HAMSA THERAPEUTICS
DEAD

Serial Number

98897961

Owner

Hamsa Therapeutics, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Dec 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

HAMSA THERAPEUTICS Trademark

Serial Number: 98897961

HAMSA THERAPEUTICS is a trademark filed by Hamsa Therapeutics, Inc. on December 11, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Hamsa Therapeutics, Inc.

One Sansome St Ste 1650
San Francisco, CA 94104

Entity Type: 03

Trademark Details

Filing Date

December 11, 2024

Registration Date

Not Registered

Published for Opposition

July 8, 2025

Goods & Services

scientific research for medical purposes in the field of muscle, metabolic, cardiovascular, renal, and respiratory diseases; research and development of therapeutics for the treatment of muscle, metabolic, cardiovascular, renal, and respiratory diseases; research and development in the field of small molecule drug discovery for muscle, metabolic, cardiovascular, renal, and respiratory diseases; medical and scientific research in the field of muscle, metabolic, cardiovascular, renal, and respiratory diseases; medical and scientific research in the field of pharmaceuticals for muscle, metabolic, cardiovascular, renal, and respiratory diseases; pharmaceutical products development in the field of muscle, metabolic, cardiovascular, renal, and respiratory diseases; drug discovery services in the field of muscle, metabolic, cardiovascular, renal, and respiratory diseases; pharmaceutical research and development services in the field of muscle, metabolic, cardiovascular, renal, and respiratory diseases; research and development in the field of precision medicine for muscle, metabolic, cardiovascular, renal, and respiratory diseases

therapeutic pharmaceuticals for the prevention and treatment of muscle, metabolic, cardiovascular, renal, and respiratory diseases; pharmaceutical preparations for the prevention and treatment of muscle, metabolic, cardiovascular, renal, and respiratory diseases; biological preparations for the prevention and treatment of muscle, metabolic, cardiovascular, renal, and respiratory diseases; biological therapies for the prevention and treatment of muscle, metabolic, cardiovascular, renal, and respiratory diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 6, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 6, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 2, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 5, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 5, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 5, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 5, 2025 CNEA
ASSIGNED TO EXAMINER
May 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
NEW APPLICATION ENTERED
Dec 11, 2024 NWAP